NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 63323-0493-91 — Lidocaine 1.5% injection solution, 20 mL vialAI (289 hospitals, 31,046–32,693 samples)
• NDC 00338-1089-04 — Amino acid and dextrose intravenous solutionAI (288 hospitals, 32,152–32,692 samples)
• NDC 00065-0647-25 — Tobramycin and dexamethasone eye dropsAI (175 hospitals, 31,732–32,686 samples)
• NDC 63739-0645-10 — Famotidine 20 mg tabletsAI (743 hospitals, 31,666–32,683 samples)
• NDC 75907-0023-11 — Clonidine 0.1 mg/24-hour transdermal patchAI (316 hospitals, 31,509–32,670 samples)
• NDC 24208-0410-05 — Ofloxacin 0.3% ear dropsAI (528 hospitals, 31,747–32,656 samples)
• NDC 70069-0017-01 — Olopatadine 0.1% eye dropsAI (293 hospitals, 31,640–32,648 samples)
• NDC 00264-7750-10 — Lactated Ringer's intravenous solutionAI (381 hospitals, 28,748–32,645 samples)
• NDC 00990-7715-13 — Mannitol 20% intravenous solutionAI (456 hospitals, 30,033–32,625 samples)
• NDC 81927-0111-01 — Nelarabine 250 mg intravenous solutionAI (89 hospitals, 32,589–32,625 samples)
• NDC 51079-0255-20 — Metoprolol tartrate 25 mg tabletsAI (814 hospitals, 31,648–32,620 samples)
• NDC 00904-6808-61 — Montelukast 10 mg tabletAI (714 hospitals, 31,745–32,618 samples)
• NDC 72578-0089-01 — Nystatin 100,000 unit/gram topical ointmentAI (272 hospitals, 31,560–32,613 samples)
• NDC 35573-0445-25 — Levalbuterol 1.25 mg/3 mL nebulizer solutionAI (174 hospitals, 31,610–32,609 samples)
• NDC 51862-0455-01 — Clonidine 0.3 mg/24 hour weekly skin patchAI (170 hospitals, 31,609–32,599 samples)
• NDC 13668-0515-01 — ACYCLOVIR 5 % TOPICAL OINTMENTAI (92 hospitals, 31,609–32,599 samples)
• NDC 00487-9501-00 — Albuterol nebulizer solution (2.5 mg)AI (148 hospitals, 31,609–32,599 samples)
• NDC 00121-0903-15 — Lidocaine 2% mucosal solutionAI (273 hospitals, 31,609–32,599 samples)
• NDC 00172-6406-05 — Cromolyn sodium nebulizer solutionAI (62 hospitals, 31,609–32,599 samples)
• NDC 69315-0308-02 — Ciprofloxacin 0.3% eye dropsAI (583 hospitals, 31,503–32,592 samples)
• NDC 24208-0486-10 — Dorzolamide-timolol eye drops, 2% and 0.5%AI (894 hospitals, 31,582–32,590 samples)
• NDC 00409-7620-03 — Heparin in saline IV solutionAI (406 hospitals, 30,571–32,587 samples)
• NDC 63323-0426-10 — Rocuronium injection, 10 mL vialAI (309 hospitals, 31,295–32,582 samples)
• NDC 50742-0190-01 — Cyproheptadine 4 mg tabletsAI (524 hospitals, 31,937–32,567 samples)
• NDC 50742-0505-01 — Scopolamine 72-hour transdermal patchAI (561 hospitals, 31,322–32,564 samples)
• NDC 80830-2329-03 — Tranexamic acid IV infusionAI (110 hospitals, 31,580–32,543 samples)
• NDC 65219-0184-20 — KETAMINE 10 MG/ML INJECTION SOLUTIONAI (242 hospitals, 31,337–32,534 samples)
• NDC 00574-4250-35 — Triple antibiotic eye ointmentAI (200 hospitals, 31,602–32,529 samples)
• NDC 70092-1046-46 — Phenylephrine and saline IV syringeAI (600 hospitals, 30,741–32,523 samples)
• NDC 72888-0125-26 — Lidocaine viscous 2% oral solutionAI (610 hospitals, 31,355–32,507 samples)
• NDC 68084-0354-01 — Oxycodone 5 mg tabletsAI (643 hospitals, 30,930–32,505 samples)
• NDC 76282-0663-39 — DICLOFENAC 1 % TOPICAL GELAI (142 hospitals, 31,599–32,499 samples)
• NDC 17478-0209-10 — ketorolac 0.5 % eye dropsAI (243 hospitals, 31,599–32,499 samples)
• NDC 00386-0001-03 — Ethyl chloride topical sprayAI (184 hospitals, 31,599–32,499 samples)
• NDC 17478-0100-12 — CYCLOPENTOLATE 1 % EYE DROPSAI (125 hospitals, 31,599–32,499 samples)
• NDC 51672-3003-02 — hydrocortisone 2.5 % topical creamAI (361 hospitals, 31,372–32,497 samples)
• NDC 00591-3510-04 — Clonidine 0.3 mg/24-hour transdermal patchAI (283 hospitals, 31,639–32,494 samples)
• NDC 00409-4887-17 — Sterile water for injectionAI (469 hospitals, 32,271–32,478 samples)
• NDC 43598-0977-10 — diclofenac 1 % topical gelAI (498 hospitals, 31,315–32,467 samples)
• NDC 00023-2181-05 — Ketorolac 0.5% eye drops, 5 mLAI (214 hospitals, 31,472–32,444 samples)
• NDC 00069-0338-01 — Sildenafil injection (intravenous)AI (156 hospitals, 31,610–32,438 samples)
• NDC 00713-0682-15 — Gentamicin sulfate 0.1% topical ointmentAI (551 hospitals, 31,295–32,438 samples)
• NDC 00006-3519-36 — DORZOLAMIDE 2 % EYE DROPSAI (203 hospitals, 31,559–32,432 samples)
• NDC 00168-0357-56 — Lidocaine-prilocaine numbing cream kitAI (193 hospitals, 31,406–32,432 samples)
• NDC 00904-6519-61 — Mirtazapine 15 mg tabletAI (620 hospitals, 31,778–32,426 samples)
• NDC 00378-9122-98 — Fentanyl 50 mcg/hr transdermal patchAI (456 hospitals, 31,586–32,423 samples)
• NDC 51672-1312-01 — mupirocin 2 % topical ointmentAI (297 hospitals, 31,386–32,421 samples)
• NDC 00407-1413-58 — Iohexol 300 contrast dye for intravenous injectionAI (91 hospitals, 31,495–32,404 samples)
• NDC 60505-0833-05 — Azelastine nasal sprayAI (697 hospitals, 31,223–32,402 samples)
• NDC 76204-0200-60 — Albuterol sulfate 2.5 mg nebulizer solutionAI (260 hospitals, 30,827–32,393 samples)